Sunil Healthcare Limited
Bombay Stock ExchangeTotal Valuation
Sunil Healthcare Limited carries a market capitalization of 634.77M, placing it among publicly traded companies globally. Its enterprise value stands at 743.49M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 634.77M |
| Enterprise Value | 743.49M |
Valuation Ratios
Sunil Healthcare Limited trades at a trailing price-to-earnings ratio of 26.06.
| PE Ratio | 26.06 |
| PS Ratio | 0.83 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Sunil Healthcare Limited trades at an EV/EBITDA multiple of 7.44 and an EV/FCF ratio of 17.19. The EV/Sales ratio of 0.83 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 7.44 provides insight into valuation relative to core operating earnings.
| EV / Sales | 0.83 |
| EV / EBITDA | 7.44 |
| EV / EBIT | 7.44 |
| EV / FCF | 17.19 |
Financial Position
Sunil Healthcare Limited maintains a current ratio of 2.06, meaning it holds 2.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 188.33, indicating elevated leverage, while an interest coverage ratio of 1.90 demonstrates limited ability to service its debt obligations.
| Current Ratio | 2.06 |
| Quick Ratio | 0.05 |
| Debt / Equity | 188.33 |
| Debt / EBITDA | N/A |
| Interest Coverage | 1.90 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 8.24 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, Sunil Healthcare Limited has paid 6.09M in income taxes, reflecting an effective tax rate of 17.59.
| Income Tax | 6.09M |
| Effective Tax Rate | 17.59 |
Stock Price Statistics
Sunil Healthcare Limited's stock has declined approximately -19.28543% over the past 52 weeks. The 50-day moving average sits at 62.92, while the 200-day moving average is 69.73.
| Beta (5Y) | N/A |
| 52-Week Price Change | -19.28543% |
| 50-Day Moving Average | 62.92 |
| 200-Day Moving Average | 69.73 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Sunil Healthcare Limited generated 891.57M in revenue and converted that into 28.53M in net income, yielding earnings per share of 2.78. EBITDA reached 99.90M, while operating income came in at 99.90M.
| Revenue | 891.57M |
| Gross Profit | 513.04M |
| Operating Income | 99.90M |
| Pretax Income | 34.62M |
| Net Income | 28.53M |
| EBITDA | 99.90M |
| EBIT | 99.90M |
| Earnings Per Share (EPS) | 2.78 |
Margins
Sunil Healthcare Limited operates with a gross margin of 57.54, reflecting its pricing power and cost economics. The operating margin of 11.20 and net profit margin of 3.20 provide insight into operational efficiency.
| Gross Margin | 57.54 |
| Operating Margin | 11.20 |
| Pretax Margin | 3.88 |
| Profit Margin | 3.20 |
| EBITDA Margin | 11.20 |
Scores
Sunil Healthcare Limited posts an Altman Z-Score of 2.30, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.30 |